CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease

Arun R. Rao, Marlon P. Quinones, Edgar Garavito, Yogeshwar Kalkonde, Fabio Jimenez, Caroline Gibbons, Jennifer Perez, Peter Melby, William Kuziel, Robert L. Reddick, Sunil K. Ahuja, Seema S. Ahuja

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The complete repertoire of cellular and molecular determinants that influence graft-vs-host disease (GVHD) is not known. Using a well-established murine model of GVHD (B6→bm12 mice), we sought to elucidate the role of the donor non-T cell compartment and molecular determinants therein in the pathogenesis of GVHD. In this model the acute GVHD-inducing effects of purified B6 wild-type (wt) CD4+ T cells was inhibited by wt non-T cells in a dose-dependent manner. Paradoxically, unlike the chronic GVHD phenotype observed in bm12 mice transplanted with B6wt unfractionated splenocytes, bm12 recipients of B6ccr2-null unfractionated splenocytes developed acute GVHD and died of IFN-γ-mediated bone marrow aplasia. This switch from chronic to acute GVHD was associated with increased target organ infiltration of activated CD4+ T cells as well as enhanced expression of Th1/Th2 cytokines, chemokines, and the antiapoptotic factor bfl1. In vitro, ccr2-/- CD4+ T cells in unfractionated splenocytes underwent significantly less activation-induced cell death than B6wt CD4+ T cells, providing another potential mechanistic basis along with enhanced expression of bfl1 for the increased numbers of activated T cells in target organs of B6ccr2 -/- splenocyte→bm12 mice. Collectively, these findings have important clinical implications, as they implicate the donor non-T cell compartment as a critical regulator of GVHD and suggest that ccr2 expression in this cellular compartment may be an important molecular determinant of activation-induced cell death and GVHD pathogenesis.

Original languageEnglish (US)
Pages (from-to)4875-4885
Number of pages11
JournalJournal of Immunology
Volume171
Issue number9
StatePublished - Oct 1 2003
Externally publishedYes

Fingerprint

CCR2 Receptors
Graft vs Host Disease
T-Lymphocytes
Cell Death
Chemokines
Bone Marrow
Cytokines

ASJC Scopus subject areas

  • Immunology

Cite this

Rao, A. R., Quinones, M. P., Garavito, E., Kalkonde, Y., Jimenez, F., Gibbons, C., ... Ahuja, S. S. (2003). CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease. Journal of Immunology, 171(9), 4875-4885.

CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease. / Rao, Arun R.; Quinones, Marlon P.; Garavito, Edgar; Kalkonde, Yogeshwar; Jimenez, Fabio; Gibbons, Caroline; Perez, Jennifer; Melby, Peter; Kuziel, William; Reddick, Robert L.; Ahuja, Sunil K.; Ahuja, Seema S.

In: Journal of Immunology, Vol. 171, No. 9, 01.10.2003, p. 4875-4885.

Research output: Contribution to journalArticle

Rao, AR, Quinones, MP, Garavito, E, Kalkonde, Y, Jimenez, F, Gibbons, C, Perez, J, Melby, P, Kuziel, W, Reddick, RL, Ahuja, SK & Ahuja, SS 2003, 'CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease', Journal of Immunology, vol. 171, no. 9, pp. 4875-4885.
Rao AR, Quinones MP, Garavito E, Kalkonde Y, Jimenez F, Gibbons C et al. CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease. Journal of Immunology. 2003 Oct 1;171(9):4875-4885.
Rao, Arun R. ; Quinones, Marlon P. ; Garavito, Edgar ; Kalkonde, Yogeshwar ; Jimenez, Fabio ; Gibbons, Caroline ; Perez, Jennifer ; Melby, Peter ; Kuziel, William ; Reddick, Robert L. ; Ahuja, Sunil K. ; Ahuja, Seema S. / CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease. In: Journal of Immunology. 2003 ; Vol. 171, No. 9. pp. 4875-4885.
@article{7cad7bf3ab1842e197cdcfd4ef727a3c,
title = "CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease",
abstract = "The complete repertoire of cellular and molecular determinants that influence graft-vs-host disease (GVHD) is not known. Using a well-established murine model of GVHD (B6→bm12 mice), we sought to elucidate the role of the donor non-T cell compartment and molecular determinants therein in the pathogenesis of GVHD. In this model the acute GVHD-inducing effects of purified B6 wild-type (wt) CD4+ T cells was inhibited by wt non-T cells in a dose-dependent manner. Paradoxically, unlike the chronic GVHD phenotype observed in bm12 mice transplanted with B6wt unfractionated splenocytes, bm12 recipients of B6ccr2-null unfractionated splenocytes developed acute GVHD and died of IFN-γ-mediated bone marrow aplasia. This switch from chronic to acute GVHD was associated with increased target organ infiltration of activated CD4+ T cells as well as enhanced expression of Th1/Th2 cytokines, chemokines, and the antiapoptotic factor bfl1. In vitro, ccr2-/- CD4+ T cells in unfractionated splenocytes underwent significantly less activation-induced cell death than B6wt CD4+ T cells, providing another potential mechanistic basis along with enhanced expression of bfl1 for the increased numbers of activated T cells in target organs of B6ccr2 -/- splenocyte→bm12 mice. Collectively, these findings have important clinical implications, as they implicate the donor non-T cell compartment as a critical regulator of GVHD and suggest that ccr2 expression in this cellular compartment may be an important molecular determinant of activation-induced cell death and GVHD pathogenesis.",
author = "Rao, {Arun R.} and Quinones, {Marlon P.} and Edgar Garavito and Yogeshwar Kalkonde and Fabio Jimenez and Caroline Gibbons and Jennifer Perez and Peter Melby and William Kuziel and Reddick, {Robert L.} and Ahuja, {Sunil K.} and Ahuja, {Seema S.}",
year = "2003",
month = "10",
day = "1",
language = "English (US)",
volume = "171",
pages = "4875--4885",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "9",

}

TY - JOUR

T1 - CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease

AU - Rao, Arun R.

AU - Quinones, Marlon P.

AU - Garavito, Edgar

AU - Kalkonde, Yogeshwar

AU - Jimenez, Fabio

AU - Gibbons, Caroline

AU - Perez, Jennifer

AU - Melby, Peter

AU - Kuziel, William

AU - Reddick, Robert L.

AU - Ahuja, Sunil K.

AU - Ahuja, Seema S.

PY - 2003/10/1

Y1 - 2003/10/1

N2 - The complete repertoire of cellular and molecular determinants that influence graft-vs-host disease (GVHD) is not known. Using a well-established murine model of GVHD (B6→bm12 mice), we sought to elucidate the role of the donor non-T cell compartment and molecular determinants therein in the pathogenesis of GVHD. In this model the acute GVHD-inducing effects of purified B6 wild-type (wt) CD4+ T cells was inhibited by wt non-T cells in a dose-dependent manner. Paradoxically, unlike the chronic GVHD phenotype observed in bm12 mice transplanted with B6wt unfractionated splenocytes, bm12 recipients of B6ccr2-null unfractionated splenocytes developed acute GVHD and died of IFN-γ-mediated bone marrow aplasia. This switch from chronic to acute GVHD was associated with increased target organ infiltration of activated CD4+ T cells as well as enhanced expression of Th1/Th2 cytokines, chemokines, and the antiapoptotic factor bfl1. In vitro, ccr2-/- CD4+ T cells in unfractionated splenocytes underwent significantly less activation-induced cell death than B6wt CD4+ T cells, providing another potential mechanistic basis along with enhanced expression of bfl1 for the increased numbers of activated T cells in target organs of B6ccr2 -/- splenocyte→bm12 mice. Collectively, these findings have important clinical implications, as they implicate the donor non-T cell compartment as a critical regulator of GVHD and suggest that ccr2 expression in this cellular compartment may be an important molecular determinant of activation-induced cell death and GVHD pathogenesis.

AB - The complete repertoire of cellular and molecular determinants that influence graft-vs-host disease (GVHD) is not known. Using a well-established murine model of GVHD (B6→bm12 mice), we sought to elucidate the role of the donor non-T cell compartment and molecular determinants therein in the pathogenesis of GVHD. In this model the acute GVHD-inducing effects of purified B6 wild-type (wt) CD4+ T cells was inhibited by wt non-T cells in a dose-dependent manner. Paradoxically, unlike the chronic GVHD phenotype observed in bm12 mice transplanted with B6wt unfractionated splenocytes, bm12 recipients of B6ccr2-null unfractionated splenocytes developed acute GVHD and died of IFN-γ-mediated bone marrow aplasia. This switch from chronic to acute GVHD was associated with increased target organ infiltration of activated CD4+ T cells as well as enhanced expression of Th1/Th2 cytokines, chemokines, and the antiapoptotic factor bfl1. In vitro, ccr2-/- CD4+ T cells in unfractionated splenocytes underwent significantly less activation-induced cell death than B6wt CD4+ T cells, providing another potential mechanistic basis along with enhanced expression of bfl1 for the increased numbers of activated T cells in target organs of B6ccr2 -/- splenocyte→bm12 mice. Collectively, these findings have important clinical implications, as they implicate the donor non-T cell compartment as a critical regulator of GVHD and suggest that ccr2 expression in this cellular compartment may be an important molecular determinant of activation-induced cell death and GVHD pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=10744233412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744233412&partnerID=8YFLogxK

M3 - Article

VL - 171

SP - 4875

EP - 4885

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 9

ER -